Cupping Therapy on Immune System in Post Covid -19
Covid-19 Patients
About this trial
This is an interventional treatment trial for Covid-19 Patients
Eligibility Criteria
Inclusion Criteria: All patients with body mass index(BMI) 25.0-29.9 kg/m2 recruited two weeks post recovary from covid-19 and have lower T-lymphocyte and elevated cytokine All patients were clinically and medically stable.All patients recruited by phone and have been offered to participate in the programme.All patients will sign the informed consent before joining the study. Age range from 21 to 66 years .Subjects will be divided equally into two groups A,B. Assessment will be done before and after treatment. Exclusion Criteria: Patients will be excluded if they have any of the following criteria: History of acute or chronic infections Hepatobiliary diseases Hematological diseases Urinary system diseases Nutrition and metabolism diseases Rheumatic diseases Endocrine diseases Circulatory system diseases Muscle trauma Hypertension Further, if they fulfilled any of the following testing criteria Hepatitis C virus antibodies Human immunodeficiency virus antibodies Creatinine above 120 μmol/L Creatine kinase above 500 U/L Uric acid above 475 μmol/L, glucose above 7.0 mmol/L C-reactive protein above 12.0 m.
Sites / Locations
- Faculty of physical therapy
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Cupping therapy with Convential medical treatment
Convential medical treatment
Cupping therapy with Convential medical treatment
Convential medical treatment